Società | Nome | Borsa | Settore | Industria | 3 mesi | Capitalizzazione di mercato | Rapporto Prezzo/Utile | Rapporto PEG | Ultimo prezzo di scambio | Variazione giornaliera (%) | Fair Value | Rialzo Fair Value | Etichetta Fair Value | Price Target (analisti) | Rialzo target analisti | Salute complessiva |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Broadcom | Lima | Tecnologia | Semiconduttori e apparecchiature per semiconduttori | 32,6% | 4,09 Bln PEN | 186x | -2,73 | 882,12 PEN | 3,3% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | ||
Meta Platforms | Lima | Tecnologia | Software e servizi IT | 21,2% | 6,83 Bln PEN | 29,5x | 0,48 | 2.683,18 PEN | 0,9% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | ||
Visa | Lima | Tecnologia | Software e servizi IT | 15% | 2,54 Bln PEN | 33,4x | 2,43 | 1.301,30 PEN | 0% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | ||
Bristol Myers Squibb | Lima | Salute | Prodotti farmaceutici | 12,9% | 423,27 Mrd PEN | -12,7x | 0,06 | 218,43 PEN | 0% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | ||
Goldman Sachs | Lima | Finanziario | Servizi bancari e di Investimenti | 9,1% | 813,38 Mrd PEN | 15,7x | 0,21 | 2.407,41 PEN | 0% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | ||
Eli Lilly | Lima | Salute | Prodotti farmaceutici | 8,7% | 2,93 Bln PEN | 74,6x | 0,73 | 3.261,73 PEN | 0% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | ||
SalesforceCom | Lima | Tecnologia | Software e servizi IT | 4,9% | 1,15 Bln PEN | 52,9x | 0,4 | 1.236,01 PEN | 0% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | ||
Mastercard | Lima | Tecnologia | Software e servizi IT | 4,1% | 1,91 Bln PEN | 40,4x | 2,29 | 1.966,64 PEN | 0% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | ||
Morgan Stanley | Lima | Finanziario | Servizi bancari e di Investimenti | 0,8% | 815,01 Mrd PEN | 17x | 0,33 | 432,14 PEN | 0% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | ||
Booking Holdings | Lima | Consumi ciclici | Servizi ricettivi e di intrattenimento | 0,2% | 611,25 Mrd PEN | 33,6x | 11,02 | 18.497,89 PEN | 34,1% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | ||
Airbnb | Lima | Tecnologia | Software e servizi IT | -2% | 327,01 Mrd PEN | 48,7x | -0,7 | 494,49 PEN | 0% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | ||
Gilead Sciences | Lima | Salute | Prodotti farmaceutici | -5,2% | 476,20 Mrd PEN | 1.020x | -9,7 | 336,66 PEN | 0% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | ||
Merck | Lima | Salute | Prodotti farmaceutici | -6,1% | 805,14 Mrd PEN | 12,7x | 0 | 356,93 PEN | 0% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | ||
NVIDIA | Lima | Tecnologia | Semiconduttori e apparecchiature per semiconduttori | -12,5% | 11,92 Bln PEN | 51,3x | 0,22 | 495,66 PEN | -0,8% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | ||
Adobe | Lima | Tecnologia | Software e servizi IT | -13% | 746,67 Mrd PEN | 37x | 7,42 | 1.704,82 PEN | 1,7% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ |